Loading…

Genetics and iron in the systems biology of Parkinson’s disease and some related disorders

► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We there...

Full description

Saved in:
Bibliographic Details
Published in:Neurochemistry international 2013-04, Vol.62 (5), p.637-652
Main Authors: Funke, Claudia, Schneider, Susanne A., Berg, Daniela, Kell, Douglas B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3
cites cdi_FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3
container_end_page 652
container_issue 5
container_start_page 637
container_title Neurochemistry international
container_volume 62
creator Funke, Claudia
Schneider, Susanne A.
Berg, Daniela
Kell, Douglas B.
description ► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We therefore provide a unifying explanation of disease development. The systems biology approach to complex diseases recognises that a potentially large number of biochemical network elements may be involved in disease progression, especially where positive feedback loops can be identified. Most of these network elements will be encoded by genes, for which different alleles may affect the network(s) differentially. A primary requirement is therefore to determine the relevant gene-network relationships. A corollary of this is that identification of the network should thereby allow one to ‘explain’ or account for any genetic associations. We apply this approach to Parkinson’s disease, a disease characterised by apoptotic death of neurons of the substantia nigra, and coupled significantly to a derangement of iron metabolism. We thereby account for the involvement of various genes and biochemical pathways associated with Parkinsonism, including seemingly unconnected ones involving iron, α-synuclein, parkin, mitochondrial respiration and biology, ceramide production, lysosome biology, Lewy body formation, and so on. Although such an analysis necessarily recognises that there is no unitary ‘cause’ of Parkinson’s, it also recognises that each of the elements contributing can or does effectively converge on a particular mode of apoptotic cell death in dopaminergic neurons, often involving iron-mediated hydroxyl radical formation. Overall, the systems biology approach allows us to propose at least one coherent synthesis of the rather disparate literature surrounding the aetiology of Parkinson’s disease, and thereby to suggest some (synergistic) targets for ameliorating the disease and its progression.
doi_str_mv 10.1016/j.neuint.2012.11.015
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1322731153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0197018612003889</els_id><sourcerecordid>1322731153</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi0EotvCG6DKRy5JPU4cJ5dKqCptpUrlADcky2uPwUtit55spb3xGrweT0KWbTlymsN8__yaj7F3IGoQ0J1t6oTbmOZaCpA1QC1AvWAr6LWsBq3al2wlYNCVgL47YsdEGyGEHoR6zY5kI6Vo-m7Fvl5hwjk64jZ5HktOPCY-f0dOO5pxIr6OeczfdjwH_smWHzFRTr9__iLuI6El_BukPCEvONoZ_X6Ri8dCb9irYEfCt0_zhH35ePn54rq6vbu6ufhwW7m2hblau1brRkLwyiqATvcyeNlb8LILKkAY-l4OWoK3YS2tkNjpblDYBi2cUrY5Ye8Pd-9LftgizWaK5HAcbcK8JQPLu7oBUM2CtgfUlUxUMJj7EidbdgaE2Xs1G3PwavZeDYBZvC6x06eG7XpC_y_0LHIBzg8ALn8-RiyGXMTk0MeCbjY-x_83_AGoBoxT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1322731153</pqid></control><display><type>article</type><title>Genetics and iron in the systems biology of Parkinson’s disease and some related disorders</title><source>ScienceDirect Freedom Collection</source><creator>Funke, Claudia ; Schneider, Susanne A. ; Berg, Daniela ; Kell, Douglas B.</creator><creatorcontrib>Funke, Claudia ; Schneider, Susanne A. ; Berg, Daniela ; Kell, Douglas B.</creatorcontrib><description>► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We therefore provide a unifying explanation of disease development. The systems biology approach to complex diseases recognises that a potentially large number of biochemical network elements may be involved in disease progression, especially where positive feedback loops can be identified. Most of these network elements will be encoded by genes, for which different alleles may affect the network(s) differentially. A primary requirement is therefore to determine the relevant gene-network relationships. A corollary of this is that identification of the network should thereby allow one to ‘explain’ or account for any genetic associations. We apply this approach to Parkinson’s disease, a disease characterised by apoptotic death of neurons of the substantia nigra, and coupled significantly to a derangement of iron metabolism. We thereby account for the involvement of various genes and biochemical pathways associated with Parkinsonism, including seemingly unconnected ones involving iron, α-synuclein, parkin, mitochondrial respiration and biology, ceramide production, lysosome biology, Lewy body formation, and so on. Although such an analysis necessarily recognises that there is no unitary ‘cause’ of Parkinson’s, it also recognises that each of the elements contributing can or does effectively converge on a particular mode of apoptotic cell death in dopaminergic neurons, often involving iron-mediated hydroxyl radical formation. Overall, the systems biology approach allows us to propose at least one coherent synthesis of the rather disparate literature surrounding the aetiology of Parkinson’s disease, and thereby to suggest some (synergistic) targets for ameliorating the disease and its progression.</description><identifier>ISSN: 0197-0186</identifier><identifier>EISSN: 1872-9754</identifier><identifier>DOI: 10.1016/j.neuint.2012.11.015</identifier><identifier>PMID: 23220386</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biocatalysis ; Brain - metabolism ; Cell Death ; GWAS ; Holistic analysis ; Humans ; Iron ; Iron - metabolism ; Organelles - metabolism ; PARK genes ; Parkinson Disease - genetics ; Parkinson Disease - metabolism ; Parkinson Disease - pathology ; Parkinson’s disease ; Systems Biology</subject><ispartof>Neurochemistry international, 2013-04, Vol.62 (5), p.637-652</ispartof><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3</citedby><cites>FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23220386$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Funke, Claudia</creatorcontrib><creatorcontrib>Schneider, Susanne A.</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Kell, Douglas B.</creatorcontrib><title>Genetics and iron in the systems biology of Parkinson’s disease and some related disorders</title><title>Neurochemistry international</title><addtitle>Neurochem Int</addtitle><description>► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We therefore provide a unifying explanation of disease development. The systems biology approach to complex diseases recognises that a potentially large number of biochemical network elements may be involved in disease progression, especially where positive feedback loops can be identified. Most of these network elements will be encoded by genes, for which different alleles may affect the network(s) differentially. A primary requirement is therefore to determine the relevant gene-network relationships. A corollary of this is that identification of the network should thereby allow one to ‘explain’ or account for any genetic associations. We apply this approach to Parkinson’s disease, a disease characterised by apoptotic death of neurons of the substantia nigra, and coupled significantly to a derangement of iron metabolism. We thereby account for the involvement of various genes and biochemical pathways associated with Parkinsonism, including seemingly unconnected ones involving iron, α-synuclein, parkin, mitochondrial respiration and biology, ceramide production, lysosome biology, Lewy body formation, and so on. Although such an analysis necessarily recognises that there is no unitary ‘cause’ of Parkinson’s, it also recognises that each of the elements contributing can or does effectively converge on a particular mode of apoptotic cell death in dopaminergic neurons, often involving iron-mediated hydroxyl radical formation. Overall, the systems biology approach allows us to propose at least one coherent synthesis of the rather disparate literature surrounding the aetiology of Parkinson’s disease, and thereby to suggest some (synergistic) targets for ameliorating the disease and its progression.</description><subject>Biocatalysis</subject><subject>Brain - metabolism</subject><subject>Cell Death</subject><subject>GWAS</subject><subject>Holistic analysis</subject><subject>Humans</subject><subject>Iron</subject><subject>Iron - metabolism</subject><subject>Organelles - metabolism</subject><subject>PARK genes</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson’s disease</subject><subject>Systems Biology</subject><issn>0197-0186</issn><issn>1872-9754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhi0EotvCG6DKRy5JPU4cJ5dKqCptpUrlADcky2uPwUtit55spb3xGrweT0KWbTlymsN8__yaj7F3IGoQ0J1t6oTbmOZaCpA1QC1AvWAr6LWsBq3al2wlYNCVgL47YsdEGyGEHoR6zY5kI6Vo-m7Fvl5hwjk64jZ5HktOPCY-f0dOO5pxIr6OeczfdjwH_smWHzFRTr9__iLuI6El_BukPCEvONoZ_X6Ri8dCb9irYEfCt0_zhH35ePn54rq6vbu6ufhwW7m2hblau1brRkLwyiqATvcyeNlb8LILKkAY-l4OWoK3YS2tkNjpblDYBi2cUrY5Ye8Pd-9LftgizWaK5HAcbcK8JQPLu7oBUM2CtgfUlUxUMJj7EidbdgaE2Xs1G3PwavZeDYBZvC6x06eG7XpC_y_0LHIBzg8ALn8-RiyGXMTk0MeCbjY-x_83_AGoBoxT</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Funke, Claudia</creator><creator>Schneider, Susanne A.</creator><creator>Berg, Daniela</creator><creator>Kell, Douglas B.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Genetics and iron in the systems biology of Parkinson’s disease and some related disorders</title><author>Funke, Claudia ; Schneider, Susanne A. ; Berg, Daniela ; Kell, Douglas B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biocatalysis</topic><topic>Brain - metabolism</topic><topic>Cell Death</topic><topic>GWAS</topic><topic>Holistic analysis</topic><topic>Humans</topic><topic>Iron</topic><topic>Iron - metabolism</topic><topic>Organelles - metabolism</topic><topic>PARK genes</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson’s disease</topic><topic>Systems Biology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Funke, Claudia</creatorcontrib><creatorcontrib>Schneider, Susanne A.</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Kell, Douglas B.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurochemistry international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Funke, Claudia</au><au>Schneider, Susanne A.</au><au>Berg, Daniela</au><au>Kell, Douglas B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetics and iron in the systems biology of Parkinson’s disease and some related disorders</atitle><jtitle>Neurochemistry international</jtitle><addtitle>Neurochem Int</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>62</volume><issue>5</issue><spage>637</spage><epage>652</epage><pages>637-652</pages><issn>0197-0186</issn><eissn>1872-9754</eissn><abstract>► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We therefore provide a unifying explanation of disease development. The systems biology approach to complex diseases recognises that a potentially large number of biochemical network elements may be involved in disease progression, especially where positive feedback loops can be identified. Most of these network elements will be encoded by genes, for which different alleles may affect the network(s) differentially. A primary requirement is therefore to determine the relevant gene-network relationships. A corollary of this is that identification of the network should thereby allow one to ‘explain’ or account for any genetic associations. We apply this approach to Parkinson’s disease, a disease characterised by apoptotic death of neurons of the substantia nigra, and coupled significantly to a derangement of iron metabolism. We thereby account for the involvement of various genes and biochemical pathways associated with Parkinsonism, including seemingly unconnected ones involving iron, α-synuclein, parkin, mitochondrial respiration and biology, ceramide production, lysosome biology, Lewy body formation, and so on. Although such an analysis necessarily recognises that there is no unitary ‘cause’ of Parkinson’s, it also recognises that each of the elements contributing can or does effectively converge on a particular mode of apoptotic cell death in dopaminergic neurons, often involving iron-mediated hydroxyl radical formation. Overall, the systems biology approach allows us to propose at least one coherent synthesis of the rather disparate literature surrounding the aetiology of Parkinson’s disease, and thereby to suggest some (synergistic) targets for ameliorating the disease and its progression.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>23220386</pmid><doi>10.1016/j.neuint.2012.11.015</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0197-0186
ispartof Neurochemistry international, 2013-04, Vol.62 (5), p.637-652
issn 0197-0186
1872-9754
language eng
recordid cdi_proquest_miscellaneous_1322731153
source ScienceDirect Freedom Collection
subjects Biocatalysis
Brain - metabolism
Cell Death
GWAS
Holistic analysis
Humans
Iron
Iron - metabolism
Organelles - metabolism
PARK genes
Parkinson Disease - genetics
Parkinson Disease - metabolism
Parkinson Disease - pathology
Parkinson’s disease
Systems Biology
title Genetics and iron in the systems biology of Parkinson’s disease and some related disorders
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A38%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetics%20and%20iron%20in%20the%20systems%20biology%20of%20Parkinson%E2%80%99s%20disease%20and%20some%20related%20disorders&rft.jtitle=Neurochemistry%20international&rft.au=Funke,%20Claudia&rft.date=2013-04-01&rft.volume=62&rft.issue=5&rft.spage=637&rft.epage=652&rft.pages=637-652&rft.issn=0197-0186&rft.eissn=1872-9754&rft_id=info:doi/10.1016/j.neuint.2012.11.015&rft_dat=%3Cproquest_cross%3E1322731153%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1322731153&rft_id=info:pmid/23220386&rfr_iscdi=true